2022
DOI: 10.1080/20002297.2022.2043651
|View full text |Cite
|
Sign up to set email alerts
|

MALDI-TOF mass spectrometry of saliva samples as a prognostic tool for COVID-19

Abstract: Background The SARS-CoV-2 infections are still imposing a great public health challenge despite the recent developments in vaccines and therapy. Searching for diagnostic and prognostic methods that are fast, low-cost and accurate are essential for disease control and patient recovery. The MALDI-TOF mass spectrometry technique is rapid, low cost and accurate when compared to other MS methods, thus its use is already reported in the literature for various applications, including microorganism identi… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 42 publications
(31 reference statements)
0
1
0
Order By: Relevance
“…All the patients included in our study had a diagnosis of COVID-19 performed by means of molecular detection of SARS-CoV-2 in nasopharyngeal swab samples, whereas the salivary presence of the virus was detected in 64.8% of subjects, showing the persistence of the virus in this fluid. This confirms the relevance of saliva sampling as a fluid with diagnostic and prognostic potential to allow for the follow-up of patients hospitalised due to COVID-19 complications, not only by detecting the virus, but also as other a biomarker of infection [ 20 , 21 , 24 , 25 ]. Among all patients examined in this present study, the majority of moderate or severe cases of COVID-19 involved male patients ( p = 0.014).…”
Section: Discussionsupporting
confidence: 57%
“…All the patients included in our study had a diagnosis of COVID-19 performed by means of molecular detection of SARS-CoV-2 in nasopharyngeal swab samples, whereas the salivary presence of the virus was detected in 64.8% of subjects, showing the persistence of the virus in this fluid. This confirms the relevance of saliva sampling as a fluid with diagnostic and prognostic potential to allow for the follow-up of patients hospitalised due to COVID-19 complications, not only by detecting the virus, but also as other a biomarker of infection [ 20 , 21 , 24 , 25 ]. Among all patients examined in this present study, the majority of moderate or severe cases of COVID-19 involved male patients ( p = 0.014).…”
Section: Discussionsupporting
confidence: 57%
“…Approaches using MALDI-TOF MS as a diagnostic tool for COVID-19 have been demonstrated. On the basis of the current reports, the detection strategy mainly relies on applying machine learning and artificial intelligence algorithms (AI/ML) to mass peaks (features) extracted from MALDI-TOF MS of either blood, saliva, or nasal swab specimens. Since the mass peaks acquired by MALDI-TOF MS are generated from human specimens, the features that drive the separation between SARS-CoV-2 positive and negative subjects are drawn from both host-response markers and pathogen signatures. As a result, researchers only report masses in MALDI-TOF MS.…”
Section: Introductionmentioning
confidence: 99%